Listen to episode 68
Episode summary
Michael Branagan Harris explains why regulatory success alone may not persuade healthcare buyers. He discusses evidence that demonstrates practical and economic value, then considers how reimbursement, provider incentives, and care delivery differences should influence the choice of launch market.
Key points
- Evidence beyond technical performance
- Affordability and operational value
- Different markets require different adoption cases